BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 17454760)

  • 1. Ductal carcinoma in situ arising in an epithelial inclusion within an axillary lymph node.
    Srinivasan B; Allan CP; Armes JE
    Pathology; 2007 Apr; 39(2):268-9. PubMed ID: 17454760
    [No Abstract]   [Full Text] [Related]  

  • 2. Synchronous ductal carcinoma in situ of the breast and within epithelial inclusions in an ipsilateral sentinel lymph node.
    Fitzpatrick-Swallow VL; Helin H; Cane P; Pinder SE
    Hum Pathol; 2013 Jan; 44(1):142-4. PubMed ID: 23089490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epitrochlear lymph node metastases from invasive ductal breast cancer.
    Kumar P; Singh S; Datta NR; Tandon A
    J Cancer Res Ther; 2009; 5(3):203-5. PubMed ID: 19841563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Occult "micrometastases" in ductal carcinoma in situ: investigative implications for sentinel lymph node biopsy.
    Weaver DL
    Cancer; 2003 Nov; 98(10):2083-7. PubMed ID: 14601075
    [No Abstract]   [Full Text] [Related]  

  • 5. [Radiotherapy of breast carcinoma. 2005 version].
    Organgruppe "Mammakarzinom" der DEGRO
    Strahlenther Onkol; 2006 Feb; 182 Suppl 1():4-28. PubMed ID: 16613299
    [No Abstract]   [Full Text] [Related]  

  • 6. [Evaluation of sentinel lymph node biopsy in detection of axillary lymph node metastasis in breast cancer].
    Zhang JG; Zhong L; Li CL
    Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):235-6. PubMed ID: 17649646
    [No Abstract]   [Full Text] [Related]  

  • 7. Papillary carcinoma arising from ectopic breast tissue in an axillary lymph node.
    Walker AN; Fechner RE
    Diagn Gynecol Obstet; 1982; 4(2):141-5. PubMed ID: 6284467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Lymphoreticular infiltrates in axillary lymph node metastases of invasive ductal breast cancers: histological and immunohistological findings].
    Horny HP; Horst HA
    Verh Dtsch Ges Pathol; 1985; 69():331-7. PubMed ID: 3006384
    [No Abstract]   [Full Text] [Related]  

  • 9. Signet ring cell histiocytosis in axillary lymph nodes: a sheep in wolves' clothing? A potentially under-recognized pitfall in the diagnosis of metastatic breast cancer.
    Pathi R; Lawrence WD; Barroeta JE
    Breast J; 2009; 15(3):302-3. PubMed ID: 19645788
    [No Abstract]   [Full Text] [Related]  

  • 10. Benign epithelial proliferations in axillary lymph nodes with ipsilateral breast in situ ductal carcinoma and intraductal papilloma of the breast.
    Liu M
    Histopathology; 2008 May; 52(6):771-3. PubMed ID: 18439159
    [No Abstract]   [Full Text] [Related]  

  • 11. [Standards of pathohistologic processing of breast cancer. A contribution to quality assurance in pathology and patient care].
    Bässler R; Schnürch HG
    Gynakologe; 1994 Feb; 27(1):23-36. PubMed ID: 8168734
    [No Abstract]   [Full Text] [Related]  

  • 12. [Micrometastases in axillary lymph nodes in breast cancer].
    Ronay G; Tomesch A; Tulusan AH
    Gynakol Rundsch; 1989; 29 Suppl 2():234-6. PubMed ID: 2558989
    [No Abstract]   [Full Text] [Related]  

  • 13. [Micrometastases of the axillary lymph nodes in breast cancer. An immunohistochemical study].
    Ronay G; Tomesch A; Tulusan AH
    Pathologe; 1989 Sep; 10(5):289-93. PubMed ID: 2477837
    [No Abstract]   [Full Text] [Related]  

  • 14. Paget's disease in metastatic breast carcinoma.
    Greenwood SM; Minkowitz S
    Arch Dermatol; 1971 Sep; 104(3):312-5. PubMed ID: 4328915
    [No Abstract]   [Full Text] [Related]  

  • 15. Breast epithelial cells in dermal angiolymphatic spaces: a manifestation of benign mechanical transport.
    Diaz NM; Mayes JR; Vrcel V
    Hum Pathol; 2005 Mar; 36(3):310-3. PubMed ID: 15791577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sentinel lymph node biopsy for breast cancer: indications, contraindications, and new directions.
    Cody HS
    J Surg Oncol; 2007 May; 95(6):440-2. PubMed ID: 17458860
    [No Abstract]   [Full Text] [Related]  

  • 17. Factors associated with lymph node assessment in ductal carcinoma in situ: analysis of 1988-2002 seer data.
    Porembka MR; Abraham RL; Sefko JA; Deshpande AD; Jeffe DB; Margenthaler JA
    Ann Surg Oncol; 2008 Oct; 15(10):2709-19. PubMed ID: 18483831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Number of lymph nodes examined and the prognosis of breast carcinoma.
    Fisher B; Slack NH
    Surg Gynecol Obstet; 1970 Jul; 131(1):79-88. PubMed ID: 5419966
    [No Abstract]   [Full Text] [Related]  

  • 19. Occult breast lesion localization plus sentinel node biopsy (SNOLL): experience with 959 patients at the European Institute of Oncology.
    Monti S; Galimberti V; Trifiro G; De Cicco C; Peradze N; Brenelli F; Fernandez-Rodriguez J; Rotmensz N; Latronico A; Berrettini A; Mauri M; Machado L; Luini A; Paganelli G
    Ann Surg Oncol; 2007 Oct; 14(10):2928-31. PubMed ID: 17674108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes for women with ductal carcinoma-in-situ and a positive sentinel node: a multi-institutional audit.
    Moore KH; Sweeney KJ; Wilson ME; Goldberg JI; Buchanan CL; Tan LK; Liberman L; Turner RR; Lagios MD; Cody Iii HS; Giuliano AE; Silverstein MJ; Van Zee KJ
    Ann Surg Oncol; 2007 Oct; 14(10):2911-7. PubMed ID: 17597346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.